Literatur
-
1
Jatoi A, Windschitl H E, Loprinzi C L.
Dronabinol versus megestrol acetate
versus combination therapy for cancer-associated anorexia: a North
Central Cancer Treatment Group Study.
J Clin Oncol.
2002;
20
567-573
-
2
Agteresch H J, Rietveld T, Kerkhofs L GM.
Beneficial effects of adenosine
triphosphate on mutritional status in advanced bung Cancer patients:
a randomized clincal trial.
J Clin Oncol.
2002;
20
371-378
-
3
Davis M P, Dickerson D.
Cachexia and anorexia:
Cancer`s covert Killer.
Support Care Cancer.
2000;
8
180-187
-
4
Body J J.
New
hopes for the treatment of cancer anorexia and cachexia?.
Opinions
Topics Support Care Oncol.
2002;
42
5-6
-
5
Dewys W D, Begg C, Lavin P T, Band P R, Bennet J M, Bertino J R, Cohen M H, Douglas H O, Engstrom P F, Ezdinli E Z, Horton J, Johnson G J, Moertel C G, Oken M M, Perlia C, Rosenbaum C, Silverstein M N, Skeel R T, Sponzo R W, Tormey D C. and the Eastern Cooperative Oncology Group .
Prognostic
effect of weight loss prior to chemotherapy in cancer patients.
Am
J Med.
1980;
69
491-497
-
6
Langstein H N, Norton J A.
Mechanisms
of cancer cachexia.
Hematol Oncol Clin North Am.
1991;
5
103-123
-
7
Kern K A, Norton J A.
Cancer cachexia.
J
Parent Ent Nutr.
1988;
12
286-298
-
8
Heber D, Byerly L O, Chlebowski R T.
Medical abnormalities in the cancer patient.
Cancer.
1985;
55
225-229
-
9
Holroyde C P, Skutches C L, Boden G.
Glucose
metabolism in cachectic patients with colorectal cancer.
Cancer
Res.
1984;
44
5910-5913
-
10
Lundholm K, Edstrom S, Karlberg I.
Glucose
turnover, gluconeogenesis from glycerol, and estimation of net glucose
cycling in cancer patients.
Cancer.
1982;
50
1142-1150
-
11
Norton J A, Maher M, Wesley R.
Glucose
intolerance in sarcoma patients.
Cancer.
1984;
54
3022-3027
-
12
Jeevanandam M, Horowitz G D, Lowry S F.
Cancer cachexia and protein metabolism.
Lancet.
1984;
i
1423-1426
-
13
Vlassara H, Spiegel R J, Doval D S.
Reduced plasma lipoproteinlipase activity
in patients with malignancy associated weight loss.
Horm Metab
Res.
1992;
18
698-703
-
14 Solassol C, Joyeux H. Artificial gut in gastrointestinal
cancer. Karger: Basel In: Beiträge
zur Infusionstherapie: Parenterale Ernährung, N Zöllner
Ed 1978: 178
-
15
McNamara M J, Alexander H R, Norton J A.
Cytokines and their role in the
pathophysiology of cancer cachexia.
J Parent Ent Nutr.
1992;
16
50-55
-
16 von Meyenfeldt M F, Soeters P B. Anorexia
in cancer. Karger: Basel In: Nutrition
in cancer and trauma sepsis. F Bozzetti, R Dionigi Eds 1985: 54-67
-
17
Holm E, Staedt U, Leweling H, Tokus M.
Metabolism und artificial
nutrition of patients with malignancy.
SA J Clin Nutr.
1993;
6
10-21
-
18 Solassol C, Joyeux H. Ambulatory parenteral
nutrition in hospital and at home. Little, Brown & Co:
Boston In: Total parenteral nutrition; JE Fischer
Ed 1975
-
19
Holland J CB, Rowland J, Plumb M.
Psychological
aspects of anorexia in cancer patients.
Cancer Res.
1977;
37
2425-2428
-
20
Keller U.
Von
der Katabolie zur Anabolie: Stoffwechselmediatoren und Therapieansätze.
Akt
Ernähr Med.
2001;
26
148-152
-
21
Gogos C A, Ginopoulos P, Salsa B.
Dietary
omega-3-polyunsaturated fatty acids plus vitamine E restore immunodeficiency
and prolong survival for severely ill patients with generalized
malignancy.
Cancer.
1998;
82
395-402
-
22
Lipman T O.
Is
enteral nutrition really letter than parenteral nutrition? A look
at the evidence.
J Parent Ent Nutr.
1998;
22
169-182
-
23
Body J J.
Metabolic
sequaelae of cancers.
Current Opin Clin Nutr and Metab
Care.
2002;
2
339-344
-
24 Ramalingaswami V, Deo M G, Sood S K. Protein deficiency in Rhesus monkey. Nutritional
Research Council. Washington D.C Publication N.
843, National Academy of Sciences 1961: 365
-
25
Deo M G, Ramalingaswani V.
Reaction of the
small intestine to induced protein malnutrition in Rhesus monkeys.
A study of cell population kinetics in the jejunum.
Gastroenterol.
1965;
49
150-157
-
26
Danon J, Gilat T.
Absorption and enzyme
studies in patients with malignancy.
Digest.
1968;
1
316
-
27
Bounous G, Hugon J M, Gentile J S.
Elemental diet in management of intestinal
lesion produced by 5-fluorouracil in man.
Can J Surg.
1971;
14
298-304
-
28
Sax H C.
Clinical
and metabolic efficacy of glutamine-supplemented parenteral nutrition
after bone marrow transplantation, A randomized, double-blind, controlled
study.
J Parent Ent Nutr.
1992;
16
589-590
-
29 Murray S M, Pindoria S. Nutrition
support for bone marrow transplant patients. (Cochrane Reriew). In:
The Cochrane Liberary, Issue 3 2002
-
30
Griffiths A M, Ohlsson A, Sherman P M, Sutherland L R.
Meta-analysis of
enteral nutrition as a primary treatment of active Crohn`s
disease.
Gastroenterol.
1995;
108
1056-1067
-
31
Woodcock N P, Zeigler D, Palmer M D, Buckley P, Mitchell C J, MacFie J.
Enteral
versus parenteral nutrition: a pragmatic study.
Nutrition.
2001;
17
1-12
-
32
Koretz R L, Lipman T O, Klein S.
American
Gastroenterological Association medical position statement: Parenteral
nutrition.
Gastroenterol.
2001;
121
966-969
-
33
Copeland E M, MacFadyen, Dudrick S J.
Intravenous hyperalimentation
in cancer patients.
J Surg Res.
1974;
16
241-246
-
34 Holm E. Ernährungstherapie
bei Tumorkrankheiten: Wird der Tumor gefüttert?. I
Karger: Basel n: Ernährung und Tumorerkrankungen.
P. Schauder, ed 1991: 454-476
-
35
Jin D, Philipps M, Byles J E.
Effects
of parenteral nutrition support and chemotherapy on the phasic composition
of tumor cells in gastrointestinal cancer.
J Parent Ent
Nutr.
1999;
23
237-241
-
36
Koretz R L, Lipman T O, Klein S.
American
Gastroenterological Association: technical review on parenteral
nutrion.
Gastroenterol.
2001;
121
970-1001
-
37
Weisdorf S, Lysne J, Wind D, Haake R J, Sharp H L, Goldman A, Schissel K, Mc Glave P B, Ramsay N K, Kersey J H.
Positive
effect of prophylactic total parenteral nutrition on long-term outcome
of bone marrow transplantation .
Transplant .
1987;
43:
833-838
-
38
Law D K, Dudrick K SJ, Abdou N J.
Immunocompetence of patients with protein-caloric
malnutrition.
Ann Int Med.
1973;
79
545-550
-
39
Copeland E M, MacFadyen B V, Rapp M A, Dudrick K SJ.
Hyperalimentation
and immune competence in cancer.
Surg Forum.
1975;
26
138-141
-
40
Blackburn G L, Maini B S, Bristrian B R, McDermott W V.
The
effect of cancer on nitrogen, electrolyte and mineral metabolim.
Cancer
Res.
1977;
37
2348-2353
-
41
Jose D G, Good R A.
Quantitative
effects of nutritional essential amino acid deficiency upon immune
response to tumor in nice.
J Exp Med.
1973;
137
1-9
-
42
Copeland E M.
Intravenous hyperalimentation and chemytherapy:
An update.
J Parent Ent Nutr.
1982;
6
236-239
-
43
Schwartz G F, G reen H L, Bendon M L, Graham W P, Blakemore W S.
Combined
parenteral hyperalimentation and chemotherapy in the treatment of
disseminated solid tumors.
Am J Surg.
1971;
121
169-173
-
44
Copeland E M, Daly J M, Dudrick K SJ.
Nutrition as an adjunct to cancer treatment
in the adult.
Cancer Res.
1977;
37
2451-2456
-
45
Souchon E A, Copeland E M, Watson P, Dudrick K SJ.
Intravenous
hyperalimentation as an adjunct to cancer chemotherapy with 5-fluorouracil.
J
Surg Res.
1975;
18
451-454
-
46
Lanzotti V J, Copeland E M, George S J, Dudrick S J, Samuels M L.
Cancer chemotherapeutic
response and intravenous hyperalimentation.
Cancer Chemother
Rep.
1975;
59
437-439
-
47
Copeland E M, MacFadyen B V, Lanzotti V J, Dudrick K SJ.
Intravenous hyperalimentation
as an adjunct to cancer chemotherapy.
J Surg.
1975;
129
167-173
-
48
King L A, Carson L F, Konstantinidis N, House M S, Adcock L L, Prem K A, Twiggs L B, Cerra F B.
Outcome assessment of home parenteral nutrition
in patients with gynecologic malignancies: what have we learned in
a decade of experience.
Gyn Oncol.
1993;
51
377-382
-
49
Cozzaglio L, Balzola F, Cosentino F, DeCicco M, Fellagra P, Gaggiotti G, Gallitelli L, Giacosa A, Orban A, Fadda M, Gavazzi C, Pirovano F, Bozzetti F.
Outcome
of cancer patients receiving home parenteral mutrition.
J
Parent Ent Nutr.
1997;
21
339-342
-
50
Wilmore D W.
Catabolic
illness: Strategies for enhancing recovery.
N Engl J Med.
1988;
12
286-298
-
51
Blackburn G L, Thornton P A.
Nutritional
assessment of hospitalized patients.
Med Clin Noth Am.
1979;
63
1103-1115
-
52
Behrendt W.
Klinisch
relevante Parameter zur Beurteilung des Ernährungszustandes.
Akt
Ernähr Med.
1999;
24
14-19
-
53
Fischer H, Lembcke B.
Die Anwendung der bioelektrischen
Impedanzanalyse (BIA) zur Beurteilung der Körperzusammensetzung
und des Ernährungszustandes.
Inn Med.
1991;
18
13-17
-
54
Jehn U, Wohlrab A, Wilmanns W.
Hinweise
zur parenteralen Ernährung von Tumor-Patienten.
Deutsch
Med Wochenschr.
1979;
15
536-540
-
55
Weisdorf S A, Lysne J, Wind D, Haake R J, Sharp H L, Goldman A, Schissel K, Mc G lave PB, Ramsay N K, Kersey J H.
Positive
effect of prophylactic total parenteral nutrition on long-term outcome
of bone marrow transplantation.
Transplant.
1987;
43
833-838
-
56
Sikora S S, Ribeiro U, Kane J M, Landreneau R J, Lembersky B, Posner M C.
Role
of nutrition support during induction chemoradiation therapy in
esophageal cancer.
J Parent Ent Nutr.
1998;
22
18-21
-
57
Baker J P, Detsky A S, Stewart S, Whitwell J, Marliss E B, Jeejeebho K N.
Randomized
trial of total parenteral nutrition in critically ill patients: metrabolic
effects of varying glucose-lipid ratios as energy source.
Gastroenterol.
1987;
87
53-59
-
58
Hallowell E, Sasvary D, Bistrian B R, Soroff H S, Blackburn G L.
Factors determining optimal nutritional
support in defined formula diet therapy (Abstract).
Clin
Res.
1975;
23
591
-
59
Howard L.
Home
parenteral nutrition in patients with a cancer diagnosis.
J
Parent Ent Nutr.
1992;
16
93-99
-
60
Solassol C, Joyeaux H.
Artificial gut with
complete nutritive mixtures as a major adjuvant therapy in cancer
patients.
Acta Chir Scand.
1979;
186-188
(Suppl 494)
-
61
Charuhas P M, Fosberg K L, Bruemmer B, Aker S N, Leisenring W, Seidel K, Sullivan K M.
A double-blind randomized trial
comparing outpatient parenteral nutrition with intra-venous hydration:
effect of resumption of oral intake after marrow transpantation.
J
Parent Ent Nutr.
1997;
21
157-161
-
62 Cahill G F, Felig E, Marliss B. Some physiological principles of parenteral
nutrition:. Grune & Stratton, New York-London In:
Body fluid replacement in surgical patient, LG Fox and GG Nahas
eds 1970: 286
-
63
Holroyde C P, Axelrod R S, Skutches C L, Haff A C, Paul P, Reichard G A.
Lactate
metabolism in patients with metastatic colorectal cancer.
Cancer
Res.
1979;
39
4900-4904
-
64
Holroyde C P, Reichard G A.
Carbohydrate
metabolism in cancer cachexia.
Cancer Treat Rep.
1981;
65
55-59
(Suppl 5)
-
65
Shaw J H, Humberstone D A, Holdaway C.
Weight loss in patients with head and neck
cancer: Malnutration or tumor effect?.
Aust NZJ Surg.
1988;
58
505-509
-
66
Waterhouse C.
Lactat
metabolism in patients with cancer.
Cancer.
1974;
33
66-71
-
67
Gold J.
Proposed
treatment of cancer by inhibition of gluconeogenesis.
Oncol.
1968;
22
185-207
-
68
Young V R.
Energy
metabolism and requirements in the cancer patient.
Cancer
Res.
1977;
37
2336-2347
-
69
Douglas R G, Shaw J HF.
Metabolic effects
of cancer.
Br J Surg.
1990;
77
246-254
-
70
Eden E, Edström S, Bennegard K, Schersten T, Lundholm K.
Glucose flux
in relation to energy expenditure in malnourished patients with and
without cancer during periods of fasting and feeding.
Cancer
Res.
1984;
44
1718-1724
-
71
Long C L, Merrick H, Grecos G, Blakemore W S, Geiger J.
Glucose
metabolism and colorectal carcinoma.
Metabolism.
1990;
39
494-501
-
72
Kohlschütter B, Jehn U.
Die parenterale
Ernährung bei aggressiver Chemotherapie verschiedener Neoplasien.
Onkol.
1978;
1
31-34
-
73 Schumer W. High
caloric solutions in traumatized patients. Grune & Stutton:
New York-London In: Body fluid replacement in the
surgical patient. CL Fox and GG Namas, eds 1970: 326
-
74 Heuckenkamp P U. Kohlehydrate-Teilaspekte der Energieversogung. Karger:
Basel In: Beiträge zur Infusionstherapie.
Parenterale Ernährung. N Zöllner ed 1978: 3
-
75
Lundholm K, Holm G, Schersten T.
Insulin
resistance in patients with cancer.
Cancer Res.
1978;
38
4665-4670
-
76
Norton J A, Maher M, Wesley R, White D, Brennan M F.
Glucose
intolerance in sarcoma patients.
Cancer.
1984;
54
3022-3027
-
77
Dudrick S J, MacFadyen B V, van Buren C T, Ruberg R L, Maynard A T.
Parenteral
hyperalimentation, metabolic problems and solutions.
Ann Surg.
1972;
176
250
-
78
Craddock P R, Yawata Y, von Sauten L, Gilberstadt S, Silvis S, Jacob H S.
Acquired
phagocyte dysfunction: A complication of the hypophosphatemic of
parenteral nutrition.
New Engl J Med.
1974;
290
1403
-
79
Dudrick S J, MacFadyen B V, Souchon E A, Englert D M, Copeland E M.
Parenteral nutrition techniques
in cancer patients.
Cancer Res.
1977;
37
2440
-
80
Paluzzi M, Meguid M M.
A prospective
randomized study of the optimal source of nonprotein calories in
total parenteral nutrition.
Surg.
1987;
102
711-717
-
81
Nordenstrom J, Askanazi J, Elwyn D H, Martin P, Carpentier Y A, Robin A P, Kinney J M.
Nitrogen balance during total parenteral
nutrition: glucose vs fat.
Ann Surg.
1983;
197
27-33
-
82
de Chalein T M, Michell W L, O`Kneefe S J, Ogden J M.
The
effect of fuel source on amino acid metabolism in critically ill
patients.
J Surg Res.
1992;
52
167-176
-
83
Jeevanandem M, Horawitz G D, Lowry S F, Brennan M F.
Cancer
cachexia and the rate of whole body lipolysis in man.
Metabolism.
1986;
35
304-310
-
84
Shaw J HF, Wolfe R R.
Fatty acid and
glycerol kinetics in septic patients and in patients with gastrointestinal
cancer.
Ann Surg.
1987;
205
368-376
-
85
Waterhouse C, Kemperman J H.
Carbohydrate
metabolism in subjects with cancer.
Cancer Res.
1971;
31
1273-1278
-
86
Lunstedt B, Deltz E, Kahler M, Bruhn A.
Randomized study comparing long-chain
(LCT) and medium-chain (MCT) triglycerides as caloric carriers in
postoperative nutritional therapy.
Infusionsther Klin
Ernaehr.
1987;
14
61-64
-
87
Jiang Z M, Zhang S Y, Wang X R, Yang N F, Zku Y, Wilmore D.
A comparison
of medium-chain and long-chain triglyceride in surgical patients.
Ann
Surg.
1993;
217
175-184
-
88
Ball M J.
Parenteral
nutrition in the critically ill: use of a medium chain triglyceride
emulsion.
Intensive Care Med.
1993;
19
89-95
-
89
Lai H, Chen W.
Effects of medium-chain
and long-chain triacylglycerols in petiatric surgical patients.
Nutrition.
2000;
16
401-406
-
90 Liljedahl S t. Parenterale Ernährung und andere
therapeutische Maßnahmen bei schweren Verbrennungen. Karger:
Basel In: Beiträge zur Infusionstherapie.
Parenterale Ernährung. N Zöllner ed 1978: 48
-
91
Pscheidl E.
Fettemulsionen - Strukturierte
Lipide und Omega-3-Fettsäuren.
Akt Ernähr
Med.
2001;
26
62-69
-
92
Chira T, Nishio K, Oke Y.
Improvement
by eicosanoids in cancer cachexia induced by LLC-116 transplantation.
J
Cancer Res Clin Oncol.
1996;
122
711-715
-
93
Wigmore St J, Ross J A, Falconer J St, Plester C E, Tisdale M J, Carter D C, Fearon K CH.
The
effect of polyunsaturated fatty acids on the progress of cachexia
in patients with pancreatic cancer.
Nutrition.
1996;
12
527-530
-
94
Bougnoux P, Germain E, Chajes V, Hubert B, Lhuillery C, Le Floch O, Body G, Calais G.
Cytotoxic drugs efficacy
correlates with adipose tissue docosahexaenoic acid level in locally
advanced breast carcinoma.
Brit J Cancer.
1999;
79
1765-1769
-
95
Baronzio G, Freitas J, Griffini P, Bertone V, Pacini F, Mascaro G, Razzini E, Gramaglia A.
Omega-3-fatty acids
can improve radioresponse modifying tumor interstitial pressure,
blood rheology and membrane peroxidability.
Anticancer
Res.
1994;
14
1145-1154
-
96 Jürgens P. Aminosäuren in der parenteralen
Ernährung. Springer: Berlin-Heidelberg-New
York In: Fettemulsionen in der parenteralen Ernährung.
A Wretlind, R Frey, K Eyrich, H Makowski eds 1977: 41
-
97
Shenkin A, Wretlind A.
Allgemeine Aspekte
hinsichtlich der intravenösen Ernährung von Krebspatienten.
Infusionsther.
1978;
5
156-165
-
98
Johnston D A, Pennington C R.
Home
parenteral intrition in Tayside 1980 - 1992.
Scottish
Med J.
1993;
38
110-111
1 Herrn Professor
em. Dr. Dr. h.c. mult. H.E. Bock zum
99. Geburtstag
Prof. Dr. U. Jehn
Medizinische Klinik III, Klinikum Großhadern
Marchioninistr. 15
81377 München
